Risk factors for severe infection and mortality In patients with COVID ‐19 in patients with multiple myeloma and AL amyloidosis

Author:

Ho Matthew1ORCID,Zanwar Saurabh2ORCID,Buadi Francis K.2,Ailawadhi Sikander3ORCID,Larsen Jeremy4,Bergsagel Leif4,Binder Moritz2ORCID,Chanan‐Khan Asher3,Dingli David2,Dispenzieri Angela2ORCID,Fonseca Rafael3,Gertz Morie A.2ORCID,Gonsalves Wilson2ORCID,Go Ronald S.2,Hayman Suzanne2,Kapoor Prashant2,Kourelis Taxiarchis2ORCID,Lacy Martha Q.2,Leung Nelson2ORCID,Lin Yi2,Muchtar Eli2ORCID,Roy Vivek3,Sher Taimur3,Warsame Rahma2ORCID,Fonder Amie2,Hobbs Miriam2,Hwa Yi L.2ORCID,Kyle Robert A.2,Rajkumar S. Vincent2ORCID,Kumar Shaji2ORCID

Affiliation:

1. Department of Internal Medicine Mayo Clinic Rochester Minnesota USA

2. Division of Hematology, Department of Internal Medicine Mayo Clinic Rochester Minnesota USA

3. Division of Hematology Mayo Clinic Jacksonville Florida USA

4. Division of Hematology Mayo Clinic Scottsdale Arizona USA

Publisher

Wiley

Subject

Hematology

Reference25 articles.

1. COVID‐19: the first documented coronavirus pandemic in history;Liu YC;Biom J,2020

2. COVID Data Tracker. Centers for Disease Control and Prevention. Accessed June 5 2022.https://covid.cdc.gov/covid-data-tracker

3. Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

4. Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

5. Remdesivir for the Treatment of Covid-19 — Final Report

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3